Beyond Air Inc (XAIR) Stock Price, Quote & News

Company Profile

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO to treat viral lung infections, such as viral community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteri...

Industry: Medical Devices

Sector: Healthcare

Phone: 516 665 8200

Website: www.beyondair.net

Address:

900 Stewart Avenue, Suite 301, Garden City, United States

JimmyOcarri Aug. 17 at 7:40 PM

$FCUV $LNZA $NXTT $UPC $XAIR gemz

0 · Reply

Say_Whaaaat Aug. 14 at 12:24 PM

$XAIR in the last 13g, they are saying this person owns 736k shares which equals 5.3%. something isn't adding up because there's only 800k total float... 🤷

1 · Reply

Zephix Aug. 13 at 9:49 PM

$XAIR $NESR Gg1

0 · Reply

LewisDaKat Aug. 13 at 6:00 PM

$XAIR Beyond Air Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update https://marketwirenews.com/stock/xair/news/beyond-air-xae-reports-financial-results-for-the-qua-7813121908546022.html?utm_source=stocktwits

0 · Reply

Gairbear Aug. 13 at 4:29 PM

I think $XAIR or $FFAI will pull a $FGI move next.

0 · Reply

StocktwitsEarnings Aug. 13 at 1:10 PM

$XAIR Q1 '27 Earnings Results & Recap Beyond Air reaffirms revenue guidance of $8 million for calendar year 2026 and $16-$18 million for calendar year 2027, which includes anticipated revenue from the second-generation LungFit PH system pending regulatory approval.

0 · Reply

MasterOfMyDomains Aug. 13 at 11:03 AM

$XAIR Nice earnings...

0 · Reply

iNVidiousGeek Aug. 11 at 9:23 PM

$XAIR LOW FLOAT!

1 · Reply

iNVidiousGeek Aug. 10 at 2:31 PM

$XAIR

0 · Reply

focafoca99 Aug. 6 at 8:52 PM

$XAIR cleared Nasdaq bid-price compliance after a 1-for-20 reverse split and earned a one-year monitoring period.

0 · Reply

Beyond Air files to sell 5.42M shares of common stock for holders

Aug 17, 2026, 8:00 AM EDT - 2 days ago

Beyond Air Registration statement: Registration filing

Aug 13, 2026, 8:00 AM EDT - 6 days ago

Beyond Air Earnings Call Transcript: Q1 2027

Aug 13, 2026, 8:00 AM EDT - 6 days ago

Beyond Air Earnings release: Q1 2027

Aug 13, 2026, 8:00 AM EDT - 6 days ago

Beyond Air Quarterly report: Q1 2027

Aug 13, 2026, 7:00 AM EDT - 6 days ago

Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update

Aug 4, 2026, 8:00 AM EDT - 15 days ago

Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026

Jul 30, 2026, 7:00 AM EDT - 20 days ago

Beyond Air® Announces Up to $30.1 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

2026-07-10T23:50:45.000Z - 5 weeks ago

Beyond Air trading halted, news pending

Jun 26, 2026, 8:00 AM EDT - 7 weeks ago

Beyond Air Earnings Call Transcript: Q4 2026

Jun 26, 2026, 8:00 AM EDT - 7 weeks ago

Beyond Air Earnings release: Q4 2026

Jun 26, 2026, 8:00 AM EDT - 7 weeks ago

Beyond Air Annual report: Q4 2026

2026-06-26T11:20:47.000Z - 7 weeks ago

Beyond Air narrows FY26 revenue view to $8M from $8M-$10M, consensus $8.08M

2026-06-26T11:20:37.000Z - 7 weeks ago

Beyond Air sees FY27 revenue $16M-$18M, consensus $12.7M

2026-06-26T11:15:15.000Z - 7 weeks ago

Beyond Air reports Q4 EPS (77c) vs. ($1.79) last year

Jun 26, 2026, 7:00 AM EDT - 7 weeks ago

Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update

Jun 22, 2026, 4:01 PM EDT - 2 months ago

Beyond Air Schedules Fiscal Year End 2026 Financial Results Conference Call and Webcast

Jun 10, 2026, 8:00 AM EDT - 2 months ago

Beyond Air, Inc. Urges Stockholders to Vote “FOR” All Proposals Ahead of the Upcoming Special Meeting

2026-06-01T13:58:00.000Z - 2 months ago

Beyond Air receives Nasdaq hearing panel decision granting continued listing

Jun 1, 2026, 8:00 AM EDT - 2 months ago

Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing

May 5, 2026, 8:00 AM EDT - 3 months ago

Beyond Air Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Beyond Air Proxy statement: Proxy filing

2026-04-20T12:58:40.000Z - 4 months ago

Beyond Air’s Beyond Cancer reports updated data from Phase 1 UNO trial

Apr 20, 2026, 8:00 AM EDT - 4 months ago

Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026

Apr 15, 2026, 8:00 AM EDT - 4 months ago

Beyond Air to Participate in the D. Boral Capital Global Conference 2026

2026-03-26T20:10:58.000Z - 5 months ago

Beyond Air CEO Steve Lisi resigns, Robert Goodman succeeds

2026-03-17T20:45:51.000Z - 5 months ago

Beyond Air subsidiary reports signs of clinical activity from UNO trial

Mar 17, 2026, 4:35 PM EDT - 5 months ago

Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial

Mar 12, 2026, 2:30 PM EDT - 5 months ago

Beyond Air Transcript: Life Sciences Virtual Investor Forum

2026-03-10T11:35:43.000Z - 5 months ago

Beyond Air announces termination of NeuroNOS agreement with XTL

XTLB

2026-02-20T13:08:00.000Z - 6 months ago

Beyond Air announces publication of review article on effects of iNO

Feb 20, 2026, 8:00 AM EST - 6 months ago

Beyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections

2026-02-19T21:31:02.000Z - 6 months ago

Beyond Air price target lowered to $2 from $6 at JonesResearch

Feb 13, 2026, 8:00 AM EST - 6 months ago

Beyond Air Earnings Call Transcript: Q3 2026

Feb 13, 2026, 8:00 AM EST - 6 months ago

Beyond Air Earnings release: Q3 2026

Feb 13, 2026, 8:00 AM EST - 6 months ago

Beyond Air Quarterly report: Q3 2026

2026-02-13T12:36:07.000Z - 6 months ago

Beyond Air reports Q3 EPS (85c) vs ($2.96) last year

2026-02-13T12:36:01.000Z - 6 months ago

Beyond Air sees FY26 revenue $8M-$10M, consensus $8.28M

Feb 13, 2026, 7:30 AM EST - 6 months ago

Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update

Feb 13, 2026, 6:00 AM EST - 6 months ago

Beyond Air Slides: Corporate presentation

2026-01-30T21:10:38.000Z - 7 months ago

Beyond Air files to sell 7.86M shares of common stock for holders

Jan 30, 2026, 7:00 AM EST - 7 months ago

Beyond Air Registration statement: Registration Filing

2026-01-29T21:40:19.000Z - 7 months ago

XTL Biopharmaceuticals provides update on recent developments

XTLB

Jan 27, 2026, 4:05 PM EST - 7 months ago

Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences

Jan 15, 2026, 1:30 PM EST - 7 months ago

Beyond Air Transcript: 2nd Annual Lytham Partners Healthcare Investor Summit

Jan 13, 2026, 7:30 AM EST - 7 months ago

XTL Biopharmaceuticals Acquires 85% of Beyond Air's Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

Dec 19, 2025, 7:00 AM EST - 8 months ago

Beyond Air Proxy statement: Proxy Filing

Dec 11, 2025, 7:00 AM EST - 8 months ago

Beyond Air Registration statement: Registration Filing

Nov 26, 2025, 4:30 PM EST - 9 months ago

Beyond Air® Announces Transition of Chief Financial Officer

Nov 21, 2025, 7:00 AM EST - 9 months ago

Beyond Air Registration statement: Registration Filing

Nov 10, 2025, 4:30 PM EST - 10 months ago

Beyond Air Earnings Call Transcript: Q2 2026

Nov 10, 2025, 4:30 PM EST - 10 months ago

Beyond Air Quarterly report: Q2 2026

Nov 10, 2025, 4:30 PM EST - 10 months ago

Beyond Air Earnings release: Q2 2026

Nov 10, 2025, 4:05 PM EST - 10 months ago

Beyond Air® Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update

Nov 10, 2025, 7:00 AM EST - 10 months ago

Beyond Air Slides: Corporate presentation

Sep 30, 2025, 8:00 AM EDT - 11 months ago

Beyond Air Registration statement: Registration Filing

Sep 25, 2025, 8:00 AM EDT - 11 months ago

Beyond Air Registration statement: Registration Filing

Sep 22, 2025, 8:00 AM EDT - 11 months ago

Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference

Sep 8, 2025, 3:55 PM EDT - 1 year ago

Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds

Sep 3, 2025, 8:00 AM EDT - 1 year ago

Beyond Air to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Aug 20, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Signs New International LungFit PH® Distribution Agreements, Most Notably in Japan

Aug 12, 2025, 4:30 PM EDT - 1 year ago

Beyond Air Earnings Call Transcript: Q1 2026

Aug 12, 2025, 4:30 PM EDT - 1 year ago

Beyond Air Earnings release: Q1 2026

Aug 12, 2025, 4:30 PM EDT - 1 year ago

Beyond Air Quarterly report: Q1 2026

Jul 25, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Schedules First Fiscal Quarter 2026 Financial Results Conference Call and Webcast

Jul 22, 2025, 7:30 AM EDT - 1 year ago

Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc.

Jun 17, 2025, 4:30 PM EDT - 1 year ago

Beyond Air Earnings Call Transcript: Q4 2025

Jun 17, 2025, 4:30 PM EDT - 1 year ago

Beyond Air Annual report: Q4 2025

Jun 17, 2025, 4:30 PM EDT - 1 year ago

Beyond Air Earnings release: Q4 2025

Jun 17, 2025, 4:01 PM EDT - 1 year ago

Beyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Jun 16, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH

May 20, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Schedules Fiscal Year End 2025 Financial Results Conference Call and Webcast

May 5, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Proxy statement: Proxy Filing

Apr 21, 2025, 4:05 PM EDT - 1 year ago

NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism

Apr 15, 2025, 4:05 PM EDT - 1 year ago

NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board

Apr 9, 2025, 4:05 PM EDT - 1 year ago

Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients' Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site

Mar 24, 2025, 4:05 PM EDT - 1 year ago

NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy

Mar 11, 2025, 7:30 AM EDT - 1 year ago

Beyond Air Announces Agreements Expanding Global Distribution of LungFit® PH

Feb 10, 2025, 4:30 PM EST - 1 year ago

Beyond Air Earnings Call Transcript: Q3 2025

Feb 10, 2025, 4:30 PM EST - 1 year ago

Beyond Air Quarterly report: Q3 2025

Feb 10, 2025, 4:30 PM EST - 1 year ago

Beyond Air Earnings release: Q3 2025

Feb 10, 2025, 4:05 PM EST - 1 year ago

Beyond Air® Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update

Feb 5, 2025, 9:29 AM EST - 1 year ago

Beyond Air® Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

Jan 31, 2025, 7:00 AM EST - 1 year ago

Beyond Air Registration statement: Registration Filing

Jan 27, 2025, 4:05 PM EST - 1 year ago

Beyond Air® Schedules Third Fiscal Quarter 2025 Financial Results Conference Call and Webcast

Jan 24, 2025, 9:15 AM EST - 1 year ago

Beyond Air® Announces LungFit® PH Receives Market Authorization in Australia

Jan 13, 2025, 10:30 AM EST - 1 year ago

Beyond Air Transcript: Lytham Partners 2025 Investor Healthcare Summit

Dec 9, 2024, 11:00 AM EST - 1 year ago

National Advertising Division Recommends Beyond Air Discontinue or Modify Comparative Safety Claims for its iNO Products

Dec 4, 2024, 4:30 PM EST - 1 year ago

Beyond Air Transcript: Piper Sandler 36th Annual Healthcare Conference

Dec 3, 2024, 4:05 PM EST - 1 year ago

Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy

Dec 2, 2024, 7:30 AM EST - 1 year ago

Beyond Air Receives CE Mark in Europe for the LungFit® PH System

Nov 26, 2024, 7:30 AM EST - 1 year ago

NeuroNOS Appoints Nobel Laureate, Roger D. Kornberg, to Scientific Advisory Board

Nov 21, 2024, 7:00 AM EST - 1 year ago

Beyond Air Registration statement: Registration Filing

Nov 14, 2024, 4:05 PM EST - 1 year ago

Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 11, 2024, 4:30 PM EST - 1 year ago

Beyond Air Earnings Call Transcript: Q2 2025

Nov 11, 2024, 4:30 PM EST - 1 year ago

Beyond Air Quarterly report: Q2 2025

Nov 11, 2024, 4:05 PM EST - 1 year ago

Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update

Oct 31, 2024, 8:00 AM EDT - 1 year ago

Beyond Air Proxy statement: Proxy Filing

Oct 29, 2024, 4:22 PM EDT - 1 year ago

Beyond Air® Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast

Oct 25, 2024, 8:00 AM EDT - 1 year ago

Beyond Air Registration statement: Registration Filing

Oct 18, 2024, 8:00 AM EDT - 1 year ago

Beyond Air Proxy statement: Proxy Filing

Oct 7, 2024, 7:00 AM EDT - 2 years ago

Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Oct 2, 2024, 7:30 AM EDT - 2 years ago

Beyond Air Partners with Healthcare Links to Expand Access to LungFit® PH System Through Group Purchasing Organizations and Integrated Delivery Networks

Sep 27, 2024, 7:34 AM EDT - 2 years ago

Beyond Air Provides LungFit® PH System to U.S. Naval Hospital Guam for Neonatal Critical Care in Partnership with TrillaMed

Sep 27, 2024, 7:32 AM EDT - 2 years ago

Beyond Air Announces Termination of the Loan and Security Agreements with Avenue Capital

Sep 27, 2024, 7:30 AM EDT - 2 years ago

Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

Sep 23, 2024, 8:00 AM EDT - 2 years ago

Beyond Air to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Aug 20, 2024, 8:00 AM EDT - 2 years ago

Beyond Air Registration statement: Registration Filing

Aug 6, 2024, 4:00 PM EDT - 2 years ago

Beyond Air Quarterly report: Q1 2025

Aug 6, 2024, 4:00 PM EDT - 2 years ago

Beyond Air Earnings release: Q1 2025

Jul 31, 2024, 4:15 PM EDT - 2 years ago

Beyond Air® Publishes Peer-Reviewed Journal Article in Scientific Reports with Clinical Data Showing Nitric Oxide was Safe and Beneficial Adjunct Therapy for Subjects with Viral Pneumonia

Jul 23, 2024, 4:05 PM EDT - 2 years ago

Beyond Air® to Report First Fiscal Quarter 2025 Financial Results on August 6

JimmyOcarri Aug. 17 at 7:40 PM

$FCUV $LNZA $NXTT $UPC $XAIR gemz

0 · Reply

Say_Whaaaat Aug. 14 at 12:24 PM

$XAIR in the last 13g, they are saying this person owns 736k shares which equals 5.3%. something isn't adding up because there's only 800k total float... 🤷

1 · Reply

Zephix Aug. 13 at 9:49 PM

$XAIR $NESR Gg1

0 · Reply

LewisDaKat Aug. 13 at 6:00 PM

0 · Reply

Gairbear Aug. 13 at 4:29 PM

I think $XAIR or $FFAI will pull a $FGI move next.

0 · Reply

StocktwitsEarnings Aug. 13 at 1:10 PM

0 · Reply

MasterOfMyDomains Aug. 13 at 11:03 AM

$XAIR Nice earnings...

0 · Reply

iNVidiousGeek Aug. 11 at 9:23 PM

$XAIR LOW FLOAT!

1 · Reply

iNVidiousGeek Aug. 10 at 2:31 PM

$XAIR

0 · Reply

focafoca99 Aug. 6 at 8:52 PM

$XAIR cleared Nasdaq bid-price compliance after a 1-for-20 reverse split and earned a one-year monitoring period.

0 · Reply

laurenlee Aug. 6 at 7:53 PM

$DFNS $MGN $CNCK $XAIR

0 · Reply

Motorhhead Aug. 6 at 4:51 PM

$DFNS $MGN $CNCK $XAIR and I thought the beppels meister had the best duds.

0 · Reply

iNVidiousGeek Aug. 5 at 12:42 PM

$XAIR LOW FLOAT! INSIDER BUYING!

1 · Reply

LewisDaKat Aug. 4 at 7:30 PM

$XAIR Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026 https://marketwirenews.com/stock/xair/news/beyond-air-schedules-conference-call-to-discuss-fina-4800348728498436.html?utm_source=stocktwits

0 · Reply

essiepaul Aug. 4 at 6:06 PM

$XAIR never seen a bigger money pit. Tell you Lisi can raise $$. Other than that…

1 · Reply

Barryman1 Aug. 4 at 8:30 AM

$XAIR 6.8$ buys 10 minutes ago !! Something is going on $DFNS today?? $CYCU hold

1 · Reply

Zardiw Aug. 3 at 11:45 PM

$DFNS just ran 122%. DDAmanda had it on radar before the move. Here's the chart. Similar early alerts: $MGN $CNCK $XAIR Find the next one: https://DDAmanda.com

0 · Reply

Barryman1 Aug. 3 at 11:10 PM

$XAIR curling up $CYCU hold $DFNS 😘

0 · Reply

Barryman1 Aug. 3 at 9:52 PM

$ENSC and $CYAB nice AH runners ! Maybe $XAIR can join 📈: RS play with nanofloat and insiders buying big

0 · Reply

Barryman1 Aug. 3 at 9:27 PM

$XAIR Hmm Patience .. I guess…

1 · Reply

MasterOfMyDomains Aug. 3 at 7:36 PM

$XAIR it lost its air

0 · Reply

Market Cap	4.11M
Revenue (ttm)	7.68M
Net Income (ttm)	-33.25M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-432.94%
Debt to Equity Ratio	7.89

Volume	17,900
Avg Vol	29,531
Day's Range	N/A - N/A
Shares Out	721,000.00
Stochastic %K	30%
Beta	0.23
Analysts	Hold
Price Target	$40.00